The immunogenic and pathogenic potential of short poly(C) tract Mengo viruses.
We have shown previously that genetically engineered Mengo viruses with artificial deletions in their 5' noncoding polyribocytidylic acid (poly(C)) tracts are highly attenuated for the natural murine host and also for other animals such as baboons, macaques, and domestic pigs. The present report further characterizes select short poly(C) tract Mengo viruses in the natural murine host. A positive correlation was found between the length of the poly(C) tract and murine virulence, as measured by virus brain titers and brain lesion scores after infection. Histological examination of brain tissue collected from infected animals clearly showed that the short poly(C) tract viruses did not induce the devastating pathological effects characteristic of animals inoculated with wild-type virus. Instead, the short-tract Mengo viruses proved excellent immunological agents. A dose of only 100 plaque-forming units of vMC24 (poly(C) tract: C13UC10), injected subcutaneously, protected 80% of recipient animals against a normally lethal dose of encephalomyocarditis virus. The protection was long-lived, and animals similarly immunized with vMCo virus (poly(C) tract: Co) still had protective neutralizing antibody titers up to 16 months after inoculation. In addition, the short-tract viruses proved genetically stable, in that the vMC24 virus did not yield detectable pathogenic revertants even after multiple, forced passages in 4-week-old mice. These studies suggest that Mengo viruses containing deletions in their poly(C) tracts are biologically safe and potent immunogens and imply that they may have uses as cardiovirus vaccines.
Osorio
J E
JE
Department of Animal Health and Biomedical Sciences, University of Wisconsin, Madison 53706, USA.
Martin
L R
LR
Palmenberg
A C
AC
D000818:Animals; D000914:Antibodies, Viral / Q000276:immunology; D001921:Brain / Q000473:pathology / Q000821:virology; D018188:Cardiovirus Infections / Q000276:immunology* / Q000821:virology; D004306:Dose-Response Relationship, Immunologic; D005260:Female; D008574:Mengovirus / Q000235:genetics* / Q000276:immunology* / Q000472:pathogenicity; D051379:Mice; D008807:Mice, Inbred BALB C; D009500:Neutralization Tests; D011066:Poly C / Q000235:genetics*; D017384:Sequence Deletion; D014611:Vaccination; D014774:Virulence
D000914:Antibodies, Viral; D011066:Poly C